PHAR’s Eunice Chang, Caleb Paydar, and Sheila R. Reddy recently published a study estimating healthcare utilization and direct medical spending among Medicaid beneficiaries with Huntington’s Disease (HD). Their analysis, done in collaboration with Genentech Inc, found that Medicaid beneficiaries with HD have higher acute healthcare utilization and costs compared to beneficiaries without HD, with utilization and costs increasing with disease progression, indicating that HD beneficiaries at later disease stages have greater burden. The full manuscript can be found in Journal of Medical Economics or on the PHAR publications page.